Search Results for citation:"89 FR 97071"

Found 2 results
Skip to main content

Search Results: citation:"89 FR 97071"

  • Type:Notice
    Citation:89 FR 97071
    Reading Time:about 2 minutes

    Noramco has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances, including Poppy Straw Concentrate and an intermediate form of Tapentadol. They plan to use these substances to manufacture other drugs for their customers. As part of their application, they also intend to import synthetic cannabidiol and synthetic Tetrahydrocannabinol, while noting that they will not import finished drugs for commercial sale. The public can submit comments or request a hearing on this application by January 6, 2025.

    Simple Explanation

    Noramco wants permission to bring certain special materials into the country to make medicine, but they won't sell these materials as final drugs. People have until January 6, 2025, to say what they think about this idea.

  • Type:Notice
    Citation:89 FR 97071
    Reading Time:about a minute or two

    The Department of Justice has announced a proposed Consent Decree with BCP Ingredients, Inc. over violations of the Clean Air Act due to the release of ethylene oxide at their Missouri facility. Under this agreement, BCP will pay a $300,000 fine, install new equipment to reduce emissions, and conduct three community projects worth $350,000. These projects include donating vehicles and medical supplies, providing medical visits, and supplying emergency response equipment. The public can comment on this decree within 30 days of its announcement.

    Simple Explanation

    The Department of Justice is asking BCP Ingredients to pay $300,000 because they let a bad gas out, and they also have to do good things like giving money and supplies to help the community. People can tell the government what they think about this plan for 30 days.